In a story written by Thomas Abraham for Bloomberg News, India may be sending health officials to China to inspect manufacturing units of bulk drug suppliers to the South Asian nation.
The Press Trust of India is citing an un-named government official, that this action may be necessary to prevent cheap imports.
According to the Press Trust of India, “Indian Health officials want to verify drugs supplied to India are made at units certified by government agencies.”
To read the entire story, visit: http://www.bloomberg.com/apps/news?pid=20601091&sid=aC4k5.Pgfv.g.
This is an ironic twist given that both India and China’s pharmaceutical industries and supply chains have a notorious reputation around the globe.
This is an ironic twist given that both India and China’s pharmaceutical industries and supply chains have a notorious reputation around the globe.
Secure Pharma Chain Blog endorses any amount of increased regulatory scrutiny within either country to protect health care consumers around the globe.
To learn more about solutions that protects the pharmaceutical supply chain, visit: http://www.xstreamsystems.net/.
Posts
No comments:
Post a Comment